KalVista Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '25 Jul 31, 2025	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Cash & Equivalents	124.3	131.62	31.79	56.24	30.73	50.59
Short-Term Investments	67.16	89	178.61	93.14	135.47	198.34
Cash & Short-Term Investments	191.47	220.62	210.4	149.38	166.2	248.93
Cash Growth	9.87%	4.86%	40.85%	-10.12%	-33.23%	267.62%
Accounts Receivable	1.93	11	-	-	-	-
Other Receivables	4.57	4.14	10.87	18.64	16.81	11.72
Receivables	6.5	15.14	10.87	18.64	16.81	11.72
Prepaid Expenses	7.93	5.93	4.42	4.31	10.64	3.62
Total Current Assets	205.9	241.69	225.69	172.33	193.65	264.26
Property, Plant & Equipment	7.23	7.53	9.15	10.77	10.04	7.55
Other Long-Term Assets	2.38	1.55	0.57	0.11	0.19	0.2
Total Assets	215.51	250.77	235.4	183.2	203.88	272.01
Accounts Payable	5.87	4.88	9.11	4.82	3.64	1.98
Accrued Expenses	18.97	27.31	12.4	9.13	6.96	6.93
Current Portion of Leases	2.12	1.98	1.3	1.09	0.98	0.86
Current Unearned Revenue	11.41	11	-	-	-	-
Total Current Liabilities	38.38	45.17	22.81	15.03	11.58	9.77
Long-Term Debt	132.32	105.88	-	-	-	-
Long-Term Leases	4.02	4.33	6.02	7.15	7.21	5.05
Total Liabilities	174.72	155.38	28.82	22.18	18.79	14.82
Common Stock	0.05	0.05	0.04	0.03	0.03	0.02
Additional Paid-In Capital	760.39	753.73	679.75	507.13	439.1	426.44
Retained Earnings	-713.27	-653.17	-469.73	-343.08	-250.18	-167.84
Comprehensive Income & Other	-6.39	-5.21	-3.49	-3.06	-3.86	-1.43
Total Common Equity	40.79	95.39	206.58	161.03	185.09	257.19
Shareholders' Equity	40.79	95.39	206.58	161.03	185.09	257.19
Total Liabilities & Equity	215.51	250.77	235.4	183.2	203.88	272.01
Total Debt	138.46	112.19	7.32	8.23	8.19	5.91
Net Cash (Debt)	53	108.43	203.08	141.14	158.01	243.02
Net Cash Growth	-68.45%	-46.61%	43.89%	-10.68%	-34.98%	267.83%
Net Cash Per Share	1.03	2.18	5.52	5.06	6.46	12.73
Filing Date Shares Outstanding	50.52	49.95	42.74	34.23	24.57	24.44
Total Common Shares Outstanding	50.34	49.76	42.52	34.17	24.55	24.42
Working Capital	167.52	196.52	202.88	157.29	182.07	254.49
Book Value Per Share	0.81	1.92	4.86	4.71	7.54	10.53
Tangible Book Value	40.79	95.39	206.58	161.03	185.09	257.19
Tangible Book Value Per Share	0.81	1.92	4.86	4.71	7.54	10.53
Machinery	-	3.64	3.08	3.05	2.6	2.01
Leasehold Improvements	-	3.09	2.86	2.86	2	1.87

Source: S&P Global Market Intelligence. Standard template. Financial Sources.